{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:00:59Z","timestamp":1793088059012,"version":"4.5.0"},"reference-count":25,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>(1) Background: Malignant (MPE), parapneumonic (PPE) and tuberculous (TPE) pleural effusions constitute common causes of pleurisy. Discriminating among them is usually challenging. C-reactive protein (CRP) and adenosine deaminase (ADA) pleural levels (p-CRP, p-ADA) have been used as differentiators in many studies showing promising results. This study aims to evaluate the diagnostic value of p-CRP, p-ADA levels and their combination among the three categories. (2) Methods: A prospective study of 100 patients with MPE (n = 59), PPE (n = 34) and TPE (n = 7) from a single centre was performed. p-CRP levels were evaluated between PPE and non-PPE and between complicated (CPPE) and non-complicated PPE. ADA levels were also measured to classify patients among MPE and non- MPE. Eventually, the combination of p-CRP and p-ADA values was used as a discrimination factor among PPE, MPE and TPE. (3) Results: ROC analysis revealed that p-CRP with a cut-off value: 4.4 mg\/dL can successfully differentiate PPE (AUC = 0.998). The cut-off level of 10 mg\/dL can predict CPPE with sensitivity: 63%, specificity: 71.4%, positive predictive value (PPV): 89%, and negative predictive value (NPV): 33%. Furthermore, patients with ADA levels \u2264 32 U\/L were more likely to belong to the malignant group sensitivity: 93%, specificity: 78%, PPV: 85.9%, and NPV: 88.9%. Discriminant analysis showed that the combination of p-CRP and p-ADA levels can discriminate PPE, MPE and TPE in 93% of cases. (4) Conclusion: This study provides evidence that p-CRP and p-ADA levels could be possibly used in clinal practice in order to establish a diagnosis among MPE, PPE and TPE.<\/jats:p>","DOI":"10.3390\/jpm11090864","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:49:51Z","timestamp":1630363791000},"page":"864","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Garifallia","family":"Perlepe","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Varsamas","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Petinaki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Antonopoulos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biotechnology, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Daniil","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-1010","authenticated-orcid":false,"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMra1403503","article-title":"Pleural Disease","volume":"378","author":"Light","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.99.5.1162","article-title":"Empyema thoracis: Factors influencing morbidity and mortality","volume":"99","author":"Ashbaugh","year":"1991","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccm.2012.11.002","article-title":"Pleural Fluid Biomarkers: Beyond the Light Criteria","volume":"34","author":"Porcel","year":"2013","journal-title":"Clin. Chest Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7539780","DOI":"10.1155\/2016\/7539780","article-title":"The diagnostic value of the pleural fluid C-reactive protein in parapneumonic effusions","volume":"2016","author":"Izhakian","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/atm.2018.11.44","article-title":"Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: A meta-analysis","volume":"7","author":"Li","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/rmed.1999.0759","article-title":"Use of pleural fluid C-reactive protein in diagnosis of pleural effusions","volume":"94","author":"Turay","year":"2000","journal-title":"Respir. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejim.2012.03.002","article-title":"Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions","volume":"23","author":"Porcel","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1378\/chest.06-2063","article-title":"Diagnosis and treatment of tuberculous pleural effusion in 2006","volume":"131","author":"Gopi","year":"2007","journal-title":"Chest"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.22371","article-title":"Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions","volume":"32","author":"Kotsiou","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1843.2010.01723.x","article-title":"Update on tuberculous pleural effusion","volume":"15","author":"Light","year":"2010","journal-title":"Respirology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09031936.03.00051603","article-title":"Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions","volume":"21","author":"Light","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3329\/akmmcj.v5i2.21132","article-title":"Adenosine Deaminase in Diagnosis of Tuberculosis: A Review","volume":"5","author":"Barua","year":"2014","journal-title":"Anwer Khan Mod. Med. Coll. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1183\/09031936.00126306","article-title":"Discrimination of exudative pleural effusions based on multiple biological parameters","volume":"30","author":"Daniil","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"i61","DOI":"10.1136\/thx.2010.137026","article-title":"Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Havelock","year":"2010","journal-title":"Thorax"},{"key":"ref_16","first-page":"CR443","article-title":"Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema","volume":"18","author":"Gilart","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jus.2008.02.001","article-title":"Role of thoracic ultrasound in the assessment of pleural and pulmonary diseases","volume":"11","author":"Sperandeo","year":"2008","journal-title":"J. Ultrasound"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1148\/radiol.10100162","article-title":"Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: Effect on survival","volume":"258","author":"Mironov","year":"2011","journal-title":"Radiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4046\/trd.2014.76.5.199","article-title":"Diagnostic tools of pleural effusion","volume":"76","author":"Na","year":"2014","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejcdt.2015.05.004","article-title":"Diagnostic significance of pleural fluid pH and pCO2","volume":"64","author":"Sobhey","year":"2015","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.amjms.2019.04.009","article-title":"Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions","volume":"358","author":"Lee","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"ref_22","first-page":"1211","article-title":"Diagnostic approach to pleural effusion in adults","volume":"73","author":"Porcel","year":"2006","journal-title":"Am. Fam. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-019-0877-8","article-title":"Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.rmed.2006.09.019","article-title":"Acute phase markers for the differentiation of infectious and malignant pleural effusions","volume":"101","author":"Kiropoulos","year":"2007","journal-title":"Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/qjmed\/hcu106","article-title":"Adenosine deaminase activity in pleural effusions of lymphoma patients","volume":"107","author":"Yao","year":"2014","journal-title":"Qjm"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/9\/864\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:55:36Z","timestamp":1760165736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/9\/864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["jpm11090864"],"URL":"https:\/\/doi.org\/10.3390\/jpm11090864","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}